Comparement of pge2 concentration in other various organs and body fluids from both human and mice with prostate cancer did not show difference compared to those from healthy cases (Figure 7C and 7D), further supporting that ABCC4 guarded the pge2 release and focal concentration in tumors. This evidence concerns the gene ABCC4 and prostate carcinoma.